NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/09/2023
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the wording "SUPERDONOR" in stylized font, with a dot to the left side of the initial "S" and also in the center of the second "O" of DONOR; the first "O" of DONOR is in a shape of a lens of a magnifying glass.
Titulares
Representantes
Yael Rouach Cabilly CABILLY & CO.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks; dietary food supplements; dietary supplement drink mixes in the nature of vitamin and mineral beverages; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; non-prescription medicines, namely, medicinal preparations in the nature of pills, tablets, capsules, caplets, liquid drops, sachets, oral liquids, suspensions, liquids, semi-solids, creams, syrups, ointments, lotions, gels, sprays, emulations, oils, pessaries, suppositories, granules and films for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of bacterial vaginosis and vaginal related women health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; medicines for dental purposes; medicines for veterinary purposes namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations and substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; pain relief medication; decongestant capsules; herbal medicines, namely, medicinal herbal preparations, herbal pharmaceutical preparations and herbal substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; antihypertensives; antitussives; diarrhea medication; antiflatulants ; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/09/2023
REGISTERED-PRINCIPAL REGISTER
05/09/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/06/2023
PUBLISHED FOR OPPOSITION
20/06/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/05/2023
ELECTRONIC RECORD REVIEW COMPLETE
15/05/2023
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/05/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2023
ASSIGNED TO EXAMINER
21/02/2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/10/2022
NON-FINAL ACTION E-MAILED
11/10/2022
NON-FINAL ACTION WRITTEN
11/10/2022
ASSIGNED TO EXAMINER
05/10/2022
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/01/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2022
NEW APPLICATION ENTERED
03/01/2022
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.